During Wednesday’s current trade, Illinois Tool Works Inc. (NYSE:ITW)’s shares incline 1.41% to $94.64.
Illinois Tool Works Inc. (ITW) declared that it will hold its 2015 second quarter conference call on Wednesday, July 22, 2015. The conference call will start at 9 a.m. central time and will follow the Company’s release of second quarter financial results at 7 a.m. central time on that same day.
Illinois Tool Works Inc. manufactures and sells industrial products and equipment worldwide. It operates through seven segments: Automotive OEM; Test & Measurement and Electronics; Food Equipment; Polymers & Fluids; Welding; Construction Products; and Specialty Products. The Automotive OEM segment produces components and fasteners for automotive-related applications. The Test & Measurement and Electronics segment provides equipment, consumables, and related software for testing and measuring of materials and structures, in addition to equipment and consumables used in the production of electronic subassemblies and microelectronics.
VimpelCom Ltd (ADR) (NASDAQ:VIP)‘s shares drop -1.30% to $5.33, during the current trading session Wednesday’s, hitting its highest level.
Bell Integrator is a partner of VimpelCom (VIP). Bell Integrator, a global consulting, technology services and outsourcing company, recently declared that it has joined the channel partner program of Equinix, Inc., the global interconnection and data Center Company, as a sales agent partner. By joining the Equinix partner program Bell Integrator is able to offer its customers the advantages of Equinix’s global footprint of colocation data centers and its advanced cloud interconnection solutions. Through this partnership, Bell Integrator will provide end-to-end services for the entire suite of Equinix offerings.
Equinix sales agent partners provide customers with the expertise needed throughout the data center implementation process. As a member of the program, Bell Integrator will assist its customers leverage more than 100+ Equinix International Business Exchange™ (IBX) data centers in 33 markets, in addition to provide access to 1,000+ networks and 500+ cloud solution providers, counting Amazon AWS and Microsoft Azure.
As an Equinix channel partner, Bell Integrator will provide a full range of IT services and expertise to offer end-to-end solutions that will be fully deployed and continually maintained.
VimpelCom Ltd. provides telecommunications services in Italy, Russia, Ukraine, Kazakhstan, Uzbekistan, Tajikistan, Armenia, Georgia, Kyrgyzstan, Laos, Algeria, Bangladesh, and Pakistan. It offers voice and data services through a range of traditional and broadband mobile and fixed line technologies. The company offers mobile telecommunications services under contract and prepaid plans for both corporate and consumer segments; value added and call completion services; national and international roaming services; wireless Internet access; mobile financial services; and mobile bundles. It also provides fixed-line telecommunication services, such as voice, data, and Internet services to corporations, operators, and consumers.
In a mid-morning trade, Organovo Holdings Inc (NYSEMKT:ONVO)‘s shares plunge -1.83% to $4.28.
Organovo Holdings, Inc. (ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D bioprinting technology, declared recently that the company will present at the forthcoming investor event, the Cantor Fitzgerald Inaugural Healthcare Conference, to be held in New York, July 8, 2015. Keith Murphy, Chairman and Chief Executive Officer, will deliver a company presentation. Mr. Murphy and Barry Michaels, Chief Financial Officer for Organovo, will be accessible for individual meetings with investors throughout the day.
Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. It is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, counting applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease for use in drug discovery and development; and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair, and functional tissue patches for the repair or replacement of damaged tissues and organs.
Dynegy Inc. (NYSE:DYN), during its Wednesday’s current trading session 0.36% gain and closed at $33.02.
Dynegy Inc. (DYN) will host an analyst meeting on Thursday, June 25, 2015. Dynegy President and Chief Executive Officer Robert C. Flexon and members of the Company’s administration team will talk about Dynegy’s strategy and key drivers of future earnings. The investor presentation will be webcast live starting at 8:00 a.m. ET Thursday.
Dynegy Inc., through its auxiliaries, produces and sells electric energy, capacity, and ancillary services in the United States. It operates in three segments, Coal, IPH, and Gas. The company sells its services on a wholesale basis from its power generation facilities. It has a fleet of 15 power plants in 5 states totaling about 13,000 megawatts of generating capacity.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
